The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.
Keri N AlthoffCameron StewartElizabeth HumesLucas GeraceCynthia M BoydKelly A GeboAmy C JusticeEmily P HyleSally B CoburnRaynell LangMichael J SilverbergMichael A HorbergViviane D LimaM John GillMaile KarrisPeter F RebeiroJennifer ThorneAshleigh J RichHeidi CraneMari M KitahataAnna RubtsovaCherise WongSean LengMahomed-Yunus MoosaGypsyamber D'SouzaHyang Nina KimSonia NapravnikKathleen McGinnisGregory D KirkTimothy R SterlingRichard D MooreParastu KasaiePublished in: PLoS medicine (2024)
The PEARL forecasts suggest a continued rise in comorbidity and multimorbidity prevalence to 2030, marked by heterogeneities across race/ethnicity, gender, and HIV acquisition risk subgroups. HIV clinicians must stay current on the ever-changing comorbidities-specific guidelines to provide guideline-recommended care. HIV clinical directors should ensure linkages to subspecialty care within the clinic or by referral. HIV policy decision-makers must allocate resources and support extended clinical capacity to meet the healthcare needs of people aging with HIV.